BMS registers observational LUNIS study of Reblozyl in lower-risk MDS patients in GermanyNov 6Weekly roundup, 3 itemsBristol Myers Squibbluspatercept
Johns Hopkins-sponsored HCC trial of Nivolumab plus Relatlimab posts results, now not recruitingOct 29Weekly roundup, 2 itemsBristol Myers Squibbnavlimetostat
BMS posts long-term SAR302503 myelofibrosis results; launches Phase III lung cancer trialOct 8Weekly roundup, 4 itemsBristol Myers Squibbiza-brenUpdated
BMS logs three FDA label approvals and posts results for melanoma combo trialSep 2Weekly roundup, 5 itemsadagrasibBristol Myers Squibb
BMS registers Phase 2 depression trial for BMS-986511; adds Alzheimer's PK study for BMS-986446Aug 21Weekly roundup, 6 itemsBristol Myers Squibbentecavir